1. Home
  2. CPAC vs TRML Comparison

CPAC vs TRML Comparison

Compare CPAC & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPAC
  • TRML
  • Stock Information
  • Founded
  • CPAC 1949
  • TRML 2021
  • Country
  • CPAC Peru
  • TRML United States
  • Employees
  • CPAC N/A
  • TRML N/A
  • Industry
  • CPAC Building Materials
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • CPAC Industrials
  • TRML Health Care
  • Exchange
  • CPAC Nasdaq
  • TRML Nasdaq
  • Market Cap
  • CPAC 497.5M
  • TRML 509.8M
  • IPO Year
  • CPAC 2012
  • TRML N/A
  • Fundamental
  • Price
  • CPAC $5.80
  • TRML $13.12
  • Analyst Decision
  • CPAC Sell
  • TRML Strong Buy
  • Analyst Count
  • CPAC 1
  • TRML 6
  • Target Price
  • CPAC $6.00
  • TRML $45.20
  • AVG Volume (30 Days)
  • CPAC 3.2K
  • TRML 377.3K
  • Earning Date
  • CPAC 04-28-2025
  • TRML 05-12-2025
  • Dividend Yield
  • CPAC 8.63%
  • TRML N/A
  • EPS Growth
  • CPAC 17.75
  • TRML N/A
  • EPS
  • CPAC 0.12
  • TRML N/A
  • Revenue
  • CPAC $524,464,683.00
  • TRML N/A
  • Revenue This Year
  • CPAC N/A
  • TRML $363.93
  • Revenue Next Year
  • CPAC N/A
  • TRML N/A
  • P/E Ratio
  • CPAC $9.48
  • TRML N/A
  • Revenue Growth
  • CPAC 1.44
  • TRML N/A
  • 52 Week Low
  • CPAC $5.10
  • TRML $11.87
  • 52 Week High
  • CPAC $6.65
  • TRML $29.79
  • Technical
  • Relative Strength Index (RSI)
  • CPAC 53.15
  • TRML 34.27
  • Support Level
  • CPAC $5.71
  • TRML $16.39
  • Resistance Level
  • CPAC $5.95
  • TRML $17.36
  • Average True Range (ATR)
  • CPAC 0.02
  • TRML 1.11
  • MACD
  • CPAC 0.01
  • TRML -0.46
  • Stochastic Oscillator
  • CPAC 90.00
  • TRML 9.76

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company that primarily produces, distributes, and sells cement and cement-related materials, such as concrete blocks and ready-mix concrete. The company's products are primarily used in construction. It also produces and sells quicklime for use in mining operations. The company sells its products mainly in the northern part of Peru. It owns three cement production facilities. Its flagship Pacasmayo facility is located in the northwest region of Peru, while its new cement plant in Piura and smaller Rioja facility are located in the northeast region of Peru.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: